Finance

Roสปyxatlar
SAILIFE:NSE
Sai Life Sciences Ltd
1ย 558,70ย โ‚น
+0,04%
(+0,60) 1K
7-okt, 15:30:00 (GMT+5:30)  ·   INR
Barcha belgilar
BelgiNarxiOสปzgartirishlarDinamika (%)
SAILIFE tikeri uchun statistika yaratilmoqda...
Ochish
1ย 558,00ย โ‚น
Yuqori
1ย 590,00ย โ‚น
Past
1ย 544,10ย โ‚น
Bozor kapitali
324,97ย mlrd
Oสปrtacha hajm
724,80ย ming
Hajmi
656,46ย ming
P/E koeffitsiyenti
91,71
52 haftalik eng yuqori
1ย 697,00ย โ‚น
52 haftalik eng past
783,85ย โ‚น
Aksiya boสปyicha daromad
17,00ย โ‚น
Xodimlar soni
5ย ming
Ochish
1ย 558,00ย โ‚น
Yuqori
1ย 590,00ย โ‚น
Past
1ย 544,10ย โ‚น
Bozor kapitali
324,97ย mlrd
Oสปrtacha hajm
724,80ย ming
Hajmi
656,46ย ming
P/E koeffitsiyenti
91,71
52 haftalik eng yuqori
1ย 697,00ย โ‚น
52 haftalik eng past
783,85ย โ‚น
Aksiya boสปyicha daromad
17,00ย โ‚น
Xodimlar soni
5ย ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Profil
Sai Life Sciences Limited is an Indian contract research, development, and manufacturing organisation, headquartered in Hyderabad, Telangana. The company provides drug discovery, development, contract manufacturing services for small-molecule new chemical entities to pharmaceutical and biotechnology companies. The company was established in Hyderabad in January 1999 as Sai Dru Syn Laboratories Limited. It was later renamed Sai Life Sciences Limited. It operates R&D and manufacturing facilities in India, the UK, and the USA. Wikipedia
Sai Life Sciences Ltd haqida
CEO-
Xodimlar soni5,22ย ming
Asos solingan1999
Bosh ofislar-
Sektor-
Veb-saytsailife.com
Oxirgi hisobot
7-avg, 2026
Moliya davri
Ch.1 2027
Aksiya boสปyicha taxminiy daromad (INR)
3,42ย โ‚น / 3,60ย โ‚น
-5,00%manfiy
Taxminiy daromad (INR)
5,54ย mlrd / 5,65ย mlrd
-1,84%manfiy
Q1 2027 uchun tushumlar hisoboti
Tushumlar hisoboti kutilmoqda
Qisqacha
Oxirgi yangiliklar va hisobotlar sarhisobi
Avvalgi hisobotlarBarcha qiymatlar โ€“ INR
Loading Previous Earnings...
Daromad
Sof foyda
Barcha qiymatlar โ€“ INR
sen, 2025
dek, 2025
mar, 2026
iyn, 2026
Daromad
5,37ย mlrd
5,56ย mlrd
6,02ย mlrd
5,54ย mlrd
Sotilgan mahsulotning tannarxi
1,40ย mlrd
1,28ย mlrd
2,27ย mlrd
1,45ย mlrd
Daromad narxi
1,40ย mlrd
1,28ย mlrd
2,27ย mlrd
1,45ย mlrd
Tadqiqot va ishlanmalarga xarajatlar
-
-
-
-
Tadqiqot va ishlanmalarga xarajatlar jami xarajatlar
-
-
-
-
Tijoriy, umumiy va maสผmuriy xarajatlar
1,63ย mlrd
1,73ย mlrd
1,96ย mlrd
1,80ย mlrd
Operatsion xarajatlar
2,91ย mlrd
2,85ย mlrd
2,43ย mlrd
3,07ย mlrd
Jami operatsion xarajatlar
4,31ย mlrd
4,13ย mlrd
4,70ย mlrd
4,52ย mlrd
Operatsion daromad
1,06ย mlrd
1,44ย mlrd
1,32ย mlrd
1,02ย mlrd
Boshqa nooperatsion daromad
153,25ย mln
83,80ย mln
-333,80ย mln
35,43ย mln
Soliq toสปlangunga qadar foyda, shu jumladan gสปayrioddiy moddalar
1,12ย mlrd
1,34ย mlrd
1,39ย mlrd
979,74ย mln
Soliq toสปlangunga qadar foyda, gสปayrioddiy moddalar bundan mustasno
1,12ย mlrd
1,42ย mlrd
1,39ย mlrd
979,74ย mln
Daromad soligสปi boสปyicha xarajat
282,07ย mln
337,91ย mln
349,91ย mln
246,89ย mln
Amaldagi soliq stavkasi
25,17%
25,19%
25,13%
25,20%
Boshqa operatsion xarajatlar
887,29ย mln
676,72ย mln
14,63ย mln
814,72ย mln
Sof foyda
838,44ย mln
1,00ย mlrd
1,04ย mlrd
732,85ย mln
Sof foyda marjasi
15,60%
18,04%
17,31%
13,22%
Har bir aksiya foydasi
3,93
5,00
4,86
3,42
Foizlar va investitsiyalardan olingan daromadlar
-
-
186,18ย mln
-
Foizlarni toสปlash xarajatlari
-93,51ย mln
-96,99ย mln
-78,25ย mln
-76,36ย mln
Foizlarni toสปlash boสปyicha sof xarajatlar
-93,51ย mln
-96,99ย mln
107,93ย mln
-76,36ย mln
Amortizatsiya ajratmalari
397,48ย mln
440,75ย mln
453,08ย mln
459,37ย mln
EBITDA
1,45ย mlrd
1,66ย mlrd
1,60ย mlrd
1,44ย mlrd
Aktivlarni sotishdan olingan foyda yoki zarar
-
-
-
-
AI kontentda xatolar boสปlishi mumkin. Batafsil
Google ilovalari